
-
China consumption slump deepens as February prices drop
-
Phone bans sweep US schools despite skepticism
-
Some 200 detained after Istanbul Women's Day march: organisers
-
'Grieving': US federal workers thrown into uncertain job market
-
Remains of murdered Indigenous woman found at Canada landfill
-
Women will overthrow Iran's Islamic republic: Nobel laureate
-
Women step into the ring at west African wrestling tournament
-
Trump's tariff rollback brings limited respite as new levies loom
-
Hackman died of natural causes, a week after wife: medical examiner
-
Oops, we tipped it again: Mission over for sideways US lander
-
Cyclone Alfred downgraded to tropical low as it nears Australia
-
Global stocks mixed as Trump shifts on tariffs weighs on sentiment
-
Trump says dairy, lumber tariffs on Canada may come soon
-
Trump cuts $400 mn from Columbia University over anti-Semitism claims
-
US Fed chair flags policy uncertainty but in no rush to adjust rates
-
Adopted orphan brings couple 'paradise' in war-ravaged Gaza
-
Oops, we tipped it again: Mission over for private US lander
-
Greenland's mining bonanza still a distant promise
-
Pope 'stable' as marks three weeks in hospital with breathless audio message
-
Shares slump on Trump tariffs tinkering, jobs
-
Mission over for private US lander after wonky landing
-
Thousands stranded as massive WWII bomb blocks Paris train station
-
UK court cuts longest jail terms on activists, rejects 10 appeals
-
US hiring misses expectations in February as jobs market faces pressure
-
S.Sudan heatwave 'more likely' due to climate change: study
-
US company says Moon mission over after landing sideways again
-
Trump says farmers keen to quit 'terrible' S. Africa welcome in US
-
US stock markets rise as investors track Trump tariffs, jobs
-
US hiring misses expectations in February, jobs market sees pressure
-
Disco, reggae on King Charles's 'eclectic' Apple playlist
-
Australian casino firm strikes deal to avoid liquidity crunch
-
Deposed king's grandson makes low-key return to Egypt
-
Stock markets, bitcoin down as Trump policies roil markets
-
Bangladesh student leader aims to finish what uprising began
-
Japan, Britain stress free trade in Tokyo talks
-
Spain targets men's 'deafening silence' in gender violence battle
-
Spain under pressure to abort nuclear energy phase-out
-
Hungary femicide sparks outcry on gender violence
-
Trial of Maradona's medics to start four years after star's death
-
Women spearhead maternal health revolution in Bangladesh
-
Apple step closer to seeing end of Indonesia iPhone sales ban
-
China's exports start year slow as US trade war intensifies
-
Asian stocks, bitcoin down as trade uncertainty roils markets
-
China tariffs aimed at Trump fan base but leave wiggle room
-
Musk's SpaceX faces new Starship setback
-
Trump signs executive order establishing 'Strategic Bitcoin Reserve'
-
Australian casino firm scrambles for cash to survive
-
Musk's SpaceX faces setback with new Starship upper stage loss
-
US and European stocks gyrate on tariffs and growth
-
Deja vu on the Moon: Private US spaceship again lands awkwardly

Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
Ng.A.Adebayo--CPN